Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+24.8%
5Y CAGR+22.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+24.8%/yr
vs +28.4%/yr prior
5Y CAGR
+22.4%/yr
Consistent
Acceleration
-3.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$76.99M+9.8%
2024$70.11M+10.4%
2023$63.50M+60.3%
2022$39.62M+26.5%
2021$31.31M+11.7%
2020$28.03M-54.4%
2019$61.53M+322.8%
2018$14.55M-